Impact of Sjögren's syndrome on quality of life and costs
Official title: The Medico-economic Impact and Quality of Life of the Small-fiber Neuropathy Associated by Using Validated Scales (SF36, DN4, PROFAD SSI, ESPRI)
Run by Assistance Publique - Hôpitaux de Paris · NCT03509064 · Data updated 2026-11-12
This study is trying to see how small fiber neuropathy affects the quality of life and costs for people with Sjögren's syndrome.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Assistance Publique - Hôpitaux de Paris Academic / other |
| Locations | 1 site (Paris) |
| Status | Recruiting |
| Started | January 14, 2019 |
| Main results expected | January 14, 2027 |
| Study ends | January 14, 2027 |
| Registry record updated | February 5, 2026 |
| Trial ID | NCT03509064 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults over 18 with a confirmed diagnosis of primary Sjögren syndrome, particularly those experiencing small fiber neuropathy.
✕Probably not a fit
Patients with other causes of peripheral neuropathy or those currently receiving biologics or immunoglobulin therapy may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to assess the impact of small fiber neuropathy (SFN) on the quality of life and the economic burden for patients with primary Sjögren's syndrome. It will involve a monocentric approach at the Lariboisière Fernand Widal Hospital, where patients will be classified into two groups: those with Sjögren's syndrome and SFN, and those without neuropathy. The study will utilize validated questionnaires to gather data on quality of life, pain, and associated healthcare costs, focusing on identifying predictors of impairment and economic impact.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into the management and support of patients with Sjögren's syndrome and SFN, potentially improving their quality of life.
How similar studies have gone: While there is ongoing research into Sjögren's syndrome and neuropathy, this specific focus on the economic and quality of life impacts is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Definite primary Sjögren syndrome * Age over 18 years * No biologics nor immunoglobulin therapy during the 6 months before study onset Arm 1: patients with a small fiber neuropathy defined by the presence of a clinical AND one paraclinical abnormality * (i) Clinical signs of small fibers involvement: thermo-algic sensory deficit or autonomic dysfunction or neuropathic pain with DN4 ≥4; * AND * (ii) Small fibers neurophysiological abnormalities (QST, laser evoked potentials, autonomic nervous system tests (sympathetic skin response test or Sudoscan®) * OR * (iii) abnormal intraepidermal nerve fiber density (skin biopsy) Arm2 (control group): patients without signs of peripheral neuropathy (small or large fiber) Exclusion Criteria: * Presence of other causes of peripheral neuropathy * Acquired: Diabetes, AL amyloidosis, Alcoholism, celiac disease, Drugs, toxic, HIV, Sarcoidosis, systemic vasculitis, Guillain-Barré syndrome. * Hereditary: Transthyretin hereditary amyloidosis (TTR), hereditary sensory and autonomic neuropathy (HSAN), Fabry's disease * Patients with impaired thermo-algic sensitivity and / or dysautonomia and / or pain with DN4 ≥ 4 AND normal diagnostic tests (normal neurophysiological tests AND normal skin biopsy) are excluded.
Where it's running
-
Département de Médecine Interne - Hôpital Lariboisière
Paris, France Recruiting
Study contacts
- Principal investigator: Damien SÈNE — Assistance Publique - Hôpitaux de Paris
- Study coordinator: Damien SÈNE, MD, PhD
- Email: damien.sene@aphp.fr
- Phone: +33149956380
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
See if small fiber neuropathy is common in people with primary Sjögren’s syndrome
This study tests whether small fiber neuropathy is common in adults with primary Sjögren’s syndrome using a quick, non-invasive Sudoscan test.
-
Magnetic Brain Stimulation for Pain in Small Fiber Neuropathy
This study tests whether repetitive transcranial magnetic stimulation (rTMS) can lessen pain in adults with idiopathic small fiber neuropathy.
-
Using PSMA and FAPI PET scans to map salivary gland function and inflammation in Sjögren's syndrome
This study will test whether combining PSMA and FAPI PET scans can better show salivary gland function and inflammation in people with primary Sjögren's syndrome.
-
Anti-CD19/BCMA U CAR-T cell therapy for relapsed or refractory autoimmune diseases
This pilot will test whether anti-CD19/BCMA U CAR-T cells can help adults with relapsed or refractory autoimmune diseases such as SLE, systemic sclerosis, Sjögren's syndrome, and rheumatoid arthritis.
-
Preoperative magnetic clip versus wire localization for breast-conserving surgery in France.
This project tests whether magnetic clips or traditional metal wires work better and cost less for women having breast-conserving surgery to locate a single, non-palpable breast cancer lesion.
-
Creating a clinical model for primary Sjögren's syndrome using both traditional Chinese and Western medicine
This study is trying to combine traditional Chinese medicine with Western medicine to see if it can improve how we diagnose and manage primary Sjögren's syndrome in patients.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.